Attention Deficit Hyperactivity Disorder, Substance Use Disorders
Conditions
Keywords
ADHD, SUD, cognitive behavioral therapy
Brief summary
The purpose of this study is to determine if cognitive behavioral therapy is effective in treating ADHD symptoms in patients with substance use disorders and comorbid ADHD.
Detailed description
Attention Deficit Hyperactivity Disorder(ADHD) is an important comorbid condition in patients with substance use disorders (SUD). The prevalence of ADHD in patients with SUD is estimated 23%, and ADHD is associated with an untoward prognosis of SUD. However, adequate treatment programs for patients with ADHD and SUD are not available. Results of medication trials for patients with ADHD and SUD are disappointing, and cognitive behavioral therapy (CBT) has not yet been investigated in this population. In patients with ADHD without comorbid SUD, the results of CBT in randomized trials are positive. The purpose of this study is to investigate if CBT is effective in treating ADHD symptoms in patients with ADHD and SUD.
Interventions
BEHAVIORALcognitive behavioral therapy for treating ADHD symptoms
5 sessions of one hour CBT for treating ADHD symptoms by a trained health care worker
Sponsors
Fonds NutsOhra
Arkin
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* substance use disorder * ADHD * able to comply with study activities
Exclusion criteria
* severe neurological or psychiatric diseases (for example Parkinson, dementia, psychosis, bipolar depression) which require medication * unable to read or write Dutch language
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| self reported ADHD symptoms | 6 months | Dutch self report list of ADHD symptoms by Kooij and Buitelaar |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Beck depression inventory | 6 months | self reported depression symptoms |
| Beck Anxiety Inventory | 6 months | Self reported anxiety symptoms |
| EQ-5 | 6 months | Self reported quality of living |
| TIC-P | 6 months | health care consumption and production loss in relation to mental health problems |
| Time Line Follow Back method | 6 months | self-reported alcohol and drug use |
| Tower of London task | 6 months | neuropsychological task |
| BART task | 6 months | neuropsychological task on risk taking behavior |
| urine checks | 6 months | urine checks on drug use |
| Stroop task | 6 months | neuropsychological measure |
Countries
Netherlands
Outcome results
None listed